Oesophageal cancer: Who needs neoadjuvant therapy?

The Lancet Oncology

Volumn 12, Issue 7, 2011, Pages 615-616

  Walsh, Thomas N ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMORBIDITY; ESOPHAGUS CANCER; HUMAN; METASTASIS; MULTIMODALITY CANCER THERAPY; NOTE; PRIORITY JOURNAL; TREATMENT RESPONSE;

EID: 79959544000     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(11)70158-9     Document Type: Letter

References (7)

1. Earlam R, Cunha-Melo JR Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg 1980, 67:381-390.
2. Verhoef C, van de Weyer R, Schaapveld M, Bastiaannet E, Plukker JT Better survival in patients with esophageal cancer after surgical treatment in university hospitals: a plea for performance by surgical oncologists. Ann Surg Oncol 2007, 14:1678-1687.
3. Sjoquist KM, Burmeister BH, Smithers BM, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol 2011, for the Australasian Gastro-Intestinal Trials Group, published online June 17. 10.1016/S1470-2045(11)70142-5.
4. Kato H, Sato A, Fukuda H, et al. A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708). Jpn J Clin Oncol 2009, 39:638-643.
5. Vallböhmer D, Hölscher AH, DeMeester S, et al. A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer. Ann Surg 2010, 252:744-749.
6. Ra J, Paulson EC, Kucharczuk J, et al. Postoperative mortality after esophagectomy for cancer: development of a preoperative risk prediction model. Ann Surg Oncol 2008, 15:1577-1584.
7. Furlong H, Gilani N, Atie M, et al. Endoscopic luminal response: does it relate to pathological response and outcome in oesophageal cancer?. Dis Esophagus 2010, 23(suppl):74A.